CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Kannact

Kannact is a human-driven digital health company that provides innovative healthcare collaboration solutions to improve the lives of patients with chronic conditions.

Nunn'S Hospital Supplies Inc

Nunn'S Hospital Supplies Inc is a Rome, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aribex

Aribex is a Orem, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lakefield Veterinary Group

Patient Choice Healthcare Inc

Patient Choice Healthcare Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.